GEN Exclusives

More »

Wall Street BioBeat

More »

You are previewing premium content. Sign up to GENSelect to read full article.

Jan 1, 2014 (Vol. 34, No. 1)

Asthma Prescription Numbers Slow Down

Monoclonal Antibodies Lead the Pipeline in the Development of Novel Therapeutics

  • The asthma prescription market is slowing as the leading drugs lose patent protection. But leading market researchers BCC and GBI Research each predict moderate ...

For full access to this content and other high value GENSelect content & services, please sign in or register for FREE below. LEARN MORE about GENSelect.

Login to GENSelect

I forgot my password

Join GENSelect for FREE

Make username same as email

I agree to the terms of genengnews.com



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Megamerger Dealzapoppin Poll

What company not in this week’s M&A headlines do you think will be at the center of a megamerger, acquisition, or partial selloff this year?